Xilio Therapeutics, Inc. (NASDAQ:XLO) Sees Large Growth in Short Interest
Xilio Therapeutics, Inc. (NASDAQ:XLO – Get Free Report) saw a significant growth in short interest in February. As of February 15th, there was short interest totalling 1,810,000 shares, a growth of 809.1% from the January 31st total of 199,100 shares. Approximately 10.7% of the shares of the stock are short sold. Based on an average […]
Xilio Therapeutics, Inc. (NASDAQ:XLO – Get Free Report) saw a significant growth in short interest in February. As of February 15th, there was short interest totalling 1,810,000 shares, a growth of 809.1% from the January 31st total of 199,100 shares. Approximately 10.7% of the shares of the stock are short sold. Based on an average […]
